1393890-33-9 他克莫司杂质14(他克莫司开环杂质)

中文名称: 他克莫司杂质14(他克莫司开环杂质)
英文名称: Tacrolimus Impurity 14
CAS号
分子式: C₄₄H₆₉NO₁₂
分子量: 804.02
更新日期: 2026-06-23

名称和标识

中文名: 他克莫司杂质14(他克莫司开环杂质)
英文名: Tacrolimus Impurity 14
CAS号: 1393890-33-9
分子式: C44H69NO12
分子量: 804.02
中文别名: 他克莫司开环杂质; 他克莫司开环杂质对照品; 他克莫司EP杂质F; 他克莫司开环杂质/杂质F(EP)/开环杂质(USP)/他克异构体I; 他克莫司开环杂质(他克莫司杂质48); 他克莫司杂质14(他克莫司EP杂质F); 他克莫司EPF; 他克莫司开环杂质1

词条详情加载中…

英文别名

Tacrolimus EP Impurity F; Tacrolimus Ring-opening Impurity; Tacrolimus Impurity 16; Tacrolimus Compound I; Tacrolimus Compound I [EP Impurity]; Tacrolimus Monohydrate Impurity F [EP Impurity]; tacrolimus ring opening; Tacrolimus Ring-opening Impurity 1; (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,26aS)-5,15-Dihydroxy-3-((1E)-1-((1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl)prop-1-en-2-yl)-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-3,4,5,6,11,12,13,14,15,16,17,18,24,25,26,26a-hexadecahydro-7H-pyrido(2,1-C)(1,4)oxaazacyclotricosine-1,7,19,20,21(8H,23H)-pentone; (5R,7S,8R,9S,11S,13E,15R,18S,19R,20S,23S)-8,18-dihydroxy-20-[(E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-7,9-dimethoxy-5,11,13,19-tetramethyl-15-prop-2-enyl-21-oxa-1-azabicyclo[21.4.0]heptacos-13-ene-2,3,4,16,22-pentone; (3S,4R,5S,8R,12S,14S,15R,16S,18R,26aS,E)-8-allyl-20-ethoxy-5,15,20-trihydroxy-3-((E)-1-((1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl)prop-1-en-2-yl)-14,16-dimethoxy-4,10,12,18-tetramethyl-3,4,5,6,11,12,13,14,15,16,17,18,24,25,26,26a-hexadecahydro-7H-pyrido[2,1-c][1]oxa[4]azacyclotricosine-1,7,19,21(8H,20H,23H)-tetraone; (3S,4R,5S,8R,12S,14S,15R,16S,18R,26aS,E)-8-allyl-5,15-dihydroxy-3-((E)-1-((1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl)prop-1-en-2-yl)-14,16-dimethoxy-4,10,12,18-tetramethyl-5,6,11,12,13,14,15,16,17,18,24,25,26,26a-tetradecahydro-3H-pyrido[2,1-c][1]oxa[4]azacyclotricosine-1,7,19,20,21(4H,8H,23H)-pentaone; 3H-PYRIDO(2,1-C)(1,4)OXAAZACYCLOTRICOSINE-1,7,19,20,21(4H,8H,23H)-PENTONE, 5,6,11,12,13,14,15,16,17,18,24,25,26,26A-TETRADECAHYDRO-5,15-DIHYDROXY-3-((1E)-2-((1R,3R,4R)-4-HYDROXY-3-METHOXYCYCLOHEXYL)-1-METHYLETHENYL)-14,16-DIMETHOXY-4,10,12,18-TETRAMETHYL-8-(2-PROPEN-1-YL)-, (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,26AS)-; 3H-Pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,19,20,21(4H,8H,23H)-pentone, 5,6,11,12,13,14,15,16,17,18,24,25,26,26a-tetradecahydro-5,15-dihydroxy-3-[(1E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propen-1-yl)-; (3S,4R,5S,8R,12S,14S,15R,16S,18R,26aS,Z)-8-Allyl-5,15-dihydroxy-3-((E)-1-((1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl)prop-1-en-2-yl)-14,16-dimethoxy-4,10,12,18-tetramethyl-5,6,11,12,13,14,15,16,17,18,24,25,26,26a-tetradecahydro-3H-pyrido[2,1-c][1]oxa[4]azacyclotricosine-1,7,19,20,21(4H,8H,23H)-pentaone